SCHEMBL1201009

SCHEMBL1201009

O=Cc1ccccc1OS(=O)(=O)C(F)(F)F

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.62
LMNA P02545 3/20 0.50
KMT2A Q03164 3/20 0.50
GAA P10253 1/20 0.50
HPGD P15428 1/20 0.48
HTT P42858 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
PTGDR2 Q9Y5Y4 1/20 0.45
SRC P12931 2/20 0.43
MEN1 O00255 2/20 0.41
THRB P10828 1/20 0.41
BLM P54132 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
TRIM24 O15164 1/20 0.39
TRIM33 Q9UPN9 1/20 0.39
DRD2 P14416 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7086093 0.84 ALDH1A1 (0.44) ALDH1A1LMNAKMT2AGAAMEN1
SCHEMBL28546606 0.83 ALDH1A1 (0.44) ALDH1A1LMNAKMT2AGAAHPGD
SCHEMBL27408036 0.83 ALDH1A1 (0.44) ALDH1A1LMNAKMT2AGAAHPGD
SCHEMBL1707904 0.83 ALDH1A1 (0.44) ALDH1A1LMNAKMT2AGAAHPGD
SCHEMBL27672302 0.83 ALDH1A1 (0.42) ALDH1A1LMNAKMT2AHTTMEN1
SCHEMBL1712875 0.82 DRD2 (0.43) ALDH1A1DRD2DRD1DRD4DRD5
SCHEMBL28576899 0.82 ALDH1A1 (0.50) ALDH1A1LMNAKMT2AGAAHPGD
SCHEMBL866808 0.81 EPAS1 (0.43) ALDH1A1PTGDR2ERN1MAPT
SCHEMBL17927449 0.81 ALDH1A1 (0.42) ALDH1A1LMNAKMT2AGAAHPGD
SCHEMBL29398687 0.81 ALDH1A1 (0.48) ALDH1A1KMT2AMEN1ERN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4680612-A1 CHEMICAL COMPOUNDS AN2 Therapeutics, Inc. (US) 2026-01-21 EP disclosed
WO-2024192309-A1 CHEMICAL COMPOUNDS REACTIVE BIOSCIENCES, INC. (US) 2024-09-19 WO disclosed
CN-114394933-A Method for synthesizing 11, 12-dihydro-gamma-oxo-dibenzo [ [ F ] azo-5- (6H) -butyric acid 厦门沃克沃德医药科技有限公司 2022-04-26 CN disclosed
US-11300877-B2 Radiation-sensitive resin composition, resist pattern-forming method and acid diffusion control agent JSR CORPORATION (JP) 2022-04-12 US disclosed
CN-111269075-B Efficient synthesis method of 2, 3-indanones 西北工业大学 2021-11-02 CN disclosed
CN-108463773-B Radiation-sensitive resin composition, resist pattern forming method, and acid diffusion controller JSR株式会社 2021-10-19 CN disclosed
CN-111269075-A Efficient synthesis method of 2, 3-indanones 西北工业大学 2020-06-12 CN disclosed
US-20180321585-A1 RADIATION-SENSITIVE RESIN COMPOSITION, RESIST PATTERN-FORMING METHOD AND ACID DIFFUSION CONTROL AGENT JSR CORPORATION (JP) 2018-11-08 US disclosed
EP-2154123-B1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2013-10-23 EP disclosed
WO-2013041807-A1 NEW TRICYCLIC COMPOUNDS, PREPARATION METHOD AND USE THEREOF CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-03-28 WO disclosed
CN-101679171-B Method for producing benzaldehyde compound SUMITOMO CHEMICAL CO 2012-12-12 CN disclosed
US-8309753-B2 Method for producing optically active cyanohydrin compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-11-13 US disclosed
US-20110034718-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRIN COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-02-10 US disclosed
EP-2264005-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRIN COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-12-22 EP disclosed
US-7851659-B2 Method for producing benzaldehyde compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-12-14 US disclosed
US-20100234645-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-16 US disclosed
CN-101679171-A Method for producing benzaldehyde compound SUMITOMO CHEMICAL CO 2010-03-24 CN disclosed
EP-2154123-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-02-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180321585-A1 RADIATION-SENSITIVE RESIN COMPOSITION, RESIST PATTERN-FORMING METHOD AND ACID DIFFUSION CONTROL AGENT RER1, RAD1, POLR1A ALDH1A1 578/4885LMNA 3264/4885KMT2A 2663/4885
US-20100234645-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND NQO1, NQO2, NDUFC2 ALDH1A1 94/4885LMNA 2113/4885KMT2A 548/4885
US-11300877-B2 Radiation-sensitive resin composition, resist pattern-forming method and acid diffusion control agent RER1, RAD1, POLR1A ALDH1A1 578/4885LMNA 3264/4885KMT2A 2663/4885
US-20110034718-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRIN COMPOUND CBR3, ACSL3, CCNL2 ALDH1A1 129/4885LMNA 441/4885KMT2A 1113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.